barr 882
Pill imprint barr 882 has been identified as Hydroxyurea 500 mg.
Hydroxyurea is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; polycythemia vera; solid tumors; psoriatic arthritis (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy.
Hydroxyurea 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydroxyurea Images
- Imprint:
-
barr
882 - Strength:
- 500 mg
- Color:
- Pink & Purple
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- citric acid monohydrate
sodium phosphate dibasic
lactose monohydrate
magnesium stearate
benzyl alcohol
isobutylparaben
D&C Red No. 28
edetate calcium disodium
FD&C Blue No. 1
FD&C Red No. 40
gelatin
ferric oxide red
methylparaben
propylparaben sodium
sodium lauryl sulfate
sodium propionate
titanium dioxide
D&C Yellow No. 10
FD&C Blue No. 2
aluminum oxide
shellac
propylene glycol
ferrosoferric oxide
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0882
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4773 | Physicians Total Care Inc (repackager) |
| 54569-5715 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Hydroxyurea resources
- Hydroxyurea (Wolters Kluwer)
- hydroxyurea (Cerner Multum)
- hydroxyurea (Micromedex) - Includes Dosage Information
- Hydroxyurea (AHFS DI)
- Hydroxyurea (FDA)
- Hydroxyurea (Wolters Kluwer)
Search Again
